Search for: "En Pointe Technologies Sales Inc" Results 1 - 20 of 97
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2024, 6:56 am by centerforartlaw
MSCHF describes themselves as a “new type of venture studio” that blends art, technology, and commerce, and markets themselves as an “art collective” with approximately 20 artists, who poke fun at contemporary trends and ride on the wave of controversy.[7] The company operates on a limited-edition drop model,[8] involving the release of a new product or experience every two weeks. [read post]
27 Feb 2024, 2:21 pm by centerforartlaw
According to Gibson’s complaint, in 2018, Gupta and Gibson came to an agreement in which both parties would retain a 50-50 split of the sale of each artwork on consignment; however, “at some point the Gallery fell behind and failed to timely remit Gibson’s full share of sales proceeds. [read post]
27 Mar 2023, 9:01 pm by renholding
For the second year in a row, the “Electronic Technology and Technology Services” and “Health Technology and Services” sectors represented over half of all filings (54%). [read post]
25 Feb 2023, 6:50 pm by admin
Yarmouth, on December 24, 1935, apparently en route from Scotland. 1936. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
  At what point do sales-with-knowledge equate with inducement? [read post]
29 Apr 2022, 5:01 am by Eugene Volokh
Kings Park Manor, Inc., for instance, the Second Circuit sitting en banc refused to hold a landlord liable for its tenants' racial harassment of fellow tenants, partly because of concern that such responsibility would pressure landlords to exercise undue power over tenants: [Under the alternative proposed by Francis,] prospective and current renters would confront more restrictive leases rife with in terrorem clauses, intensified tenant screening procedures, and intrusions… [read post]
5 Jan 2022, 7:16 am
  The case, In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ) MDL No. 2875 (RBK)is a products liability case that concerns the sale in the U.S. of generic, prescription Valsartan pharmaceuticals, found by the Food and Drug Administration [“FDA”] to contain cancer‐causing contaminants. [read post]
22 Sep 2021, 2:51 pm by Jonathan H. Adler
This point is especially important here, where the opinions arising from our deeply divided panel became moot before the Court's en banc process could be undertaken. [read post]
18 Apr 2021, 7:48 am by Eric Goldman
Most importantly, it is not a point of sale; all purchases must occur at the store. [read post]
8 Sep 2020, 3:44 pm by David Kopel
The Third Circuit, Sept. 1, upheld by 2-1 confiscation in New Jersey in Association of New Jersey Rifle and Pistol Clubs Inc v. [read post]